The Meningococcal Vaccines Market To Transcend The Covid-19 Barrier From 2029 OnPosted by Ashish on December 24th, 2020 The meningococcal vaccine market has expanded to a significant extent over the past few years in correspondence to the parent market. Constant research and development in meningococcal vaccines for various meningococcal disease preventive applications, coupled with the sanctions of subsidy & support of government organizations for immunization program are among the significant factors that are anticipated to drive the growth of the meningococcal vaccine market during the forecast period. Expansion of the age group indication related to new sero-groups is boosting the potential population pool, thus boosting the market growth. As per the latest research by PMR, the global meningococcal vaccine market is estimated to account for ~ US$ 6.5 billion in terms of revenue by the end of 2029. Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3640 Company Profiles:
Like it? Share it!More by this author |